Clinical Trials Browser

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Epstein-Barr Virus Infections

NCT02309437 2018-07-17

Early Use of Opioid in Radiation Mucositis

Phase 2 Completed

200 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Nutrition Disorders, Pain

NCT02776124 2018-03-19

Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients

Phase 2 Completed

60 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03427359 2018-02-09

Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Phase 2 Completed

65 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00953420 2017-08-18

CADEN

Phase 2 Completed

20 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT01326559 2017-08-16

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

Phase 2 Completed

33 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01370070 2017-01-13

MC1079

Phase 2 Completed

12 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02360501 2016-04-20

Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma

Phase 2 Completed

50 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT01616849 2015-09-22

Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma

Phase 2 Completed

39 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00565448 2015-07-30

Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

Phase 2 Completed

75 enrolled 10 charts

Head & Neck

Nasopharyngeal Carcinoma, Carcinoma, Nasopharyngeal Neoplasms

NCT00697905 2014-11-21

Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma

Phase 2 Completed

18 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00815087 2014-03-26

Functional Electrical Stimulation in Irradiated Nasopharyngeal Carcinoma (NPC)

Phase 2 Completed

20 enrolled 6 charts

Head & Neck

Nasopharyngeal Carcinoma, Deglutition Disorders

NCT01865201 2013-12-12

Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis

Phase 2 Completed

154 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01271439 2013-08-13

REPLACE

Phase 2 Completed

60 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00700440 2010-03-26

ENCORE

Phase 2 Completed

100 enrolled 4 charts

Head & Neck

Nasopharyngeal Carcinoma

Clinical Trials

Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)

Consolidation Pembrolizumab After Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

PLATINUM

Neoadjuvant Therapy of GP Chemotherapy Combined With Tislelizumab in Locoregionally Advanced NPC

A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma

A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma

Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL)

A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma

A Study of a PD-1/CTLA-4 Bispecific Antibody AK104 in Patients With Metastatic Nasopharyngeal Carcinoma

Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC

Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.

Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing Radiotherapy

Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy

KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma

A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma

Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Nedaplatin in Treatment for Nasopharyngeal Carcinoma

Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma

Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma

Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy

S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma

Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)

Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients

Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRT

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

BRAIN

Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

Early Use of Opioid in Radiation Mucositis

Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients

Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

CADEN

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

MC1079

Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma

Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma

Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma

Functional Electrical Stimulation in Irradiated Nasopharyngeal Carcinoma (NPC)

Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis

REPLACE

ENCORE